201 related articles for article (PubMed ID: 21324901)
1. Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin.
To WS; Midwood KS
J Biol Chem; 2011 Apr; 286(17):14881-91. PubMed ID: 21324901
[TBL] [Abstract][Full Text] [Related]
2. Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis.
To WS; Midwood KS
Matrix Biol; 2010 Sep; 29(7):573-85. PubMed ID: 20708078
[TBL] [Abstract][Full Text] [Related]
3. Localization of a cryptic binding site for tenascin on fibronectin.
Ingham KC; Brew SA; Erickson HP
J Biol Chem; 2004 Jul; 279(27):28132-5. PubMed ID: 15123658
[TBL] [Abstract][Full Text] [Related]
4. Binding of tenascin-C to soluble fibronectin and matrix fibrils.
Chung CY; Zardi L; Erickson HP
J Biol Chem; 1995 Dec; 270(48):29012-7. PubMed ID: 7499434
[TBL] [Abstract][Full Text] [Related]
5. Backbone dynamics of homologous fibronectin type III cell adhesion domains from fibronectin and tenascin.
Carr PA; Erickson HP; Palmer AG
Structure; 1997 Jul; 5(7):949-59. PubMed ID: 9261088
[TBL] [Abstract][Full Text] [Related]
6. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
[TBL] [Abstract][Full Text] [Related]
7. Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin.
Weber P; Ferber P; Fischer R; Winterhalter KH; Vaughan L
FEBS Lett; 1996 Jul; 389(3):304-8. PubMed ID: 8766721
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C.
Chung CY; Erickson HP
J Cell Sci; 1997 Jun; 110 ( Pt 12)():1413-9. PubMed ID: 9217327
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a conformational heparin-binding site involving two fibronectin type III modules of bovine tenascin-X.
Lethias C; Elefteriou F; Parsiegla G; Exposito JY; Garrone R
J Biol Chem; 2001 May; 276(19):16432-8. PubMed ID: 11278641
[TBL] [Abstract][Full Text] [Related]
10. A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly.
Sechler JL; Rao H; Cumiskey AM; Vega-Colón I; Smith MS; Murata T; Schwarzbauer JE
J Cell Biol; 2001 Sep; 154(5):1081-8. PubMed ID: 11535624
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins.
Day JM; Olin AI; Murdoch AD; Canfield A; Sasaki T; Timpl R; Hardingham TE; Aspberg A
J Biol Chem; 2004 Mar; 279(13):12511-8. PubMed ID: 14722076
[TBL] [Abstract][Full Text] [Related]
12. Ligation of the fibrin-binding domain by β-strand addition is sufficient for expansion of soluble fibronectin.
Maurer LM; Ma W; Eickstaedt NL; Johnson IA; Tomasini-Johansson BR; Annis DS; Mosher DF
J Biol Chem; 2012 Apr; 287(16):13303-12. PubMed ID: 22351755
[TBL] [Abstract][Full Text] [Related]
13. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.
Ambort D; Brellier F; Becker-Pauly C; Stöcker W; Andrejevic-Blant S; Chiquet M; Sterchi EE
Matrix Biol; 2010 Jan; 29(1):31-42. PubMed ID: 19748582
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin.
Hocking DC; Sottile J; McKeown-Longo PJ
J Biol Chem; 1994 Jul; 269(29):19183-7. PubMed ID: 8034677
[TBL] [Abstract][Full Text] [Related]
15. Mapping of a defined neurocan binding site to distinct domains of tenascin-C.
Rauch U; Clement A; Retzler C; Fröhlich L; Fässler R; Göhring W; Faissner A
J Biol Chem; 1997 Oct; 272(43):26905-12. PubMed ID: 9341124
[TBL] [Abstract][Full Text] [Related]
16. The role of integrin binding sites in fibronectin matrix assembly in vivo.
Leiss M; Beckmann K; Girós A; Costell M; Fässler R
Curr Opin Cell Biol; 2008 Oct; 20(5):502-7. PubMed ID: 18586094
[TBL] [Abstract][Full Text] [Related]
17. Heparin-fibronectin interactions in the development of extracellular matrix insolubility.
Raitman I; Huang ML; Williams SA; Friedman B; Godula K; Schwarzbauer JE
Matrix Biol; 2018 Apr; 67():107-122. PubMed ID: 29223498
[TBL] [Abstract][Full Text] [Related]
18. Identification of the fibronectin sequences required for assembly of a fibrillar matrix.
Schwarzbauer JE
J Cell Biol; 1991 Jun; 113(6):1463-73. PubMed ID: 2045422
[TBL] [Abstract][Full Text] [Related]
19. Modulating the mechanical stability of extracellular matrix protein tenascin-C in a controlled and reversible fashion.
Zhuang S; Peng Q; Cao Y; Li H
J Mol Biol; 2009 Jul; 390(4):820-9. PubMed ID: 19477181
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin.
Hauzenberger D; Olivier P; Gundersen D; Rüegg C
Eur J Immunol; 1999 May; 29(5):1435-47. PubMed ID: 10359097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
